1. Home
  2. OSIS vs NVCR Comparison

OSIS vs NVCR Comparison

Compare OSIS & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSIS
  • NVCR
  • Stock Information
  • Founded
  • OSIS 1987
  • NVCR 2000
  • Country
  • OSIS United States
  • NVCR Switzerland
  • Employees
  • OSIS N/A
  • NVCR N/A
  • Industry
  • OSIS Industrial Machinery/Components
  • NVCR Medical/Dental Instruments
  • Sector
  • OSIS Technology
  • NVCR Health Care
  • Exchange
  • OSIS Nasdaq
  • NVCR Nasdaq
  • Market Cap
  • OSIS 3.3B
  • NVCR 2.3B
  • IPO Year
  • OSIS 1997
  • NVCR 2015
  • Fundamental
  • Price
  • OSIS $175.31
  • NVCR $20.06
  • Analyst Decision
  • OSIS Strong Buy
  • NVCR Buy
  • Analyst Count
  • OSIS 6
  • NVCR 5
  • Target Price
  • OSIS $205.17
  • NVCR $33.40
  • AVG Volume (30 Days)
  • OSIS 230.1K
  • NVCR 1.1M
  • Earning Date
  • OSIS 04-24-2025
  • NVCR 05-01-2025
  • Dividend Yield
  • OSIS N/A
  • NVCR N/A
  • EPS Growth
  • OSIS 18.05
  • NVCR N/A
  • EPS
  • OSIS 7.78
  • NVCR N/A
  • Revenue
  • OSIS $1,650,140,000.00
  • NVCR $605,220,000.00
  • Revenue This Year
  • OSIS $12.56
  • NVCR $3.41
  • Revenue Next Year
  • OSIS $5.14
  • NVCR $9.24
  • P/E Ratio
  • OSIS $21.95
  • NVCR N/A
  • Revenue Growth
  • OSIS 20.69
  • NVCR 18.82
  • 52 Week Low
  • OSIS $126.57
  • NVCR $11.70
  • 52 Week High
  • OSIS $220.00
  • NVCR $34.13
  • Technical
  • Relative Strength Index (RSI)
  • OSIS 32.67
  • NVCR 42.06
  • Support Level
  • OSIS $177.00
  • NVCR $17.10
  • Resistance Level
  • OSIS $189.15
  • NVCR $21.55
  • Average True Range (ATR)
  • OSIS 8.28
  • NVCR 1.27
  • MACD
  • OSIS -3.46
  • NVCR 0.28
  • Stochastic Oscillator
  • OSIS 39.63
  • NVCR 56.96

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. Majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East, and Africa, and the Asia Pacific regions.

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: